大挑战述评：个性化医学的信息诊断。
Grand challenge commentary: Informative diagnostics for personalized medicine.
机构信息
Department of Chemistry, Institute for Genomic Biology, and the Micro and Nanotechnology Laboratory, University of Illinois at Urbana-Champaign, Urbana, Illinois, USA.
出版信息
Nat Chem Biol. 2010 Dec;6(12):857-9. doi: 10.1038/nchembio.488.
Abstract
Some of the most celebrated triumphs of chemical biology are molecularly targeted therapeutics to combat human disease. However, a grand challenge looms as informative diagnostic strategies must be developed to realize the full impact of these promising pharmaceutical agents.
摘要
化学生物学的一些最著名的成就就是针对人类疾病的分子靶向治疗药物。然而，一个巨大的挑战摆在面前，因为必须开发有信息价值的诊断策略，才能充分发挥这些有前途的药物制剂的作用。
相似文献
1
Grand challenge commentary: Informative diagnostics for personalized medicine.大挑战述评：个性化医学的信息诊断。
Nat Chem Biol. 2010 Dec;6(12):857-9. doi: 10.1038/nchembio.488.
2
Companion diagnostics: the next step in personalized clinical care.伴随诊断：个性化临床护理的下一步。
Genet Test Mol Biomarkers. 2012 Oct;16(10):1155-6. doi: 10.1089/gtmb.2012.1539.
3
Toward multiomics-based next-generation diagnostics for precision medicine.迈向基于多组学的精准医学下一代诊断技术。
Per Med. 2019 Mar;16(2):157-170. doi: 10.2217/pme-2018-0085. Epub 2019 Feb 28.
4
Role of Proteomics in the Development of Personalized Medicine.蛋白质组学在个性化医疗发展中的作用。
Adv Protein Chem Struct Biol. 2016;102:41-52. doi: 10.1016/bs.apcsb.2015.09.002. Epub 2015 Nov 11.
5
Precision medicine: what's all the fuss about?精准医学：究竟在大惊小怪些什么？
Scand J Clin Lab Invest Suppl. 2016;245:S2-5. doi: 10.1080/00365513.2016.1206434. Epub 2016 Aug 17.
6
Protein shakes - the future is not here yet for proteomic - based companion diagnostics, but it's coming.蛋白质奶昔——基于蛋白质组学的伴随诊断的未来尚未到来，但它即将来临。
Mol Oncol. 2011 Jun;5(3):220-3. doi: 10.1016/j.molonc.2011.04.003.
7
Implementing personalized cancer genomics in clinical trials.在临床试验中实施个体化癌症基因组学。
Nat Rev Drug Discov. 2013 May;12(5):358-69. doi: 10.1038/nrd3979.
8
Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine.系统癌症医学：迈向实现预测性、预防性、个体化和参与性（P4）医学。
J Intern Med. 2012 Feb;271(2):111-21. doi: 10.1111/j.1365-2796.2011.02498.x.
9
Biomarkers for precision medicine in airways disease.气道疾病精准医学的生物标志物
Ann N Y Acad Sci. 2015 Jun;1346(1):18-32. doi: 10.1111/nyas.12809.
10
Genetics and genomics: the scientific drivers of personalized medicine.遗传学与基因组学：个性化医疗的科学驱动力。
Annu Rev Nurs Res. 2011;29:27-54. doi: 10.1891/0739-6686.29.27.
引用本文的文献
1
On silico peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactions.基于硅基肽微阵列的高分辨率抗体表位作图和多种蛋白质-蛋白质相互作用研究
Nat Med. 2012 Sep;18(9):1434-40. doi: 10.1038/nm.2913.
2
Resources and costs for microbial sequence analysis evaluated using virtual machines and cloud computing.利用虚拟机和云计算评估微生物序列分析的资源和成本。
PLoS One. 2011;6(10):e26624. doi: 10.1371/journal.pone.0026624. Epub 2011 Oct 19.
本文引用的文献
1
Discovery and canine preclinical assessment of a nontoxic procaspase-3-activating compound.一种无毒的半胱天冬酶-3激活化合物的发现及犬类临床前评估。
Cancer Res. 2010 Sep 15;70(18):7232-41. doi: 10.1158/0008-5472.CAN-10-0766. Epub 2010 Sep 7.
2
Applications of aptamers as sensors.适体作为传感器的应用。
Annu Rev Anal Chem (Palo Alto Calif). 2009;2:241-64. doi: 10.1146/annurev.anchem.1.031207.112851.
3
Pharmacological reactivation of mutant p53: from protein structure to the cancer patient.突变型 p53 的药理学再激活：从蛋白质结构到癌症患者。
Oncogene. 2010 Jul 29;29(30):4245-52. doi: 10.1038/onc.2010.188. Epub 2010 May 24.
4
The application of mass-spectrometry-based protein biomarker discovery to theragnostics.基于质谱的蛋白质生物标志物发现在治疗学中的应用。
Br J Clin Pharmacol. 2010 Apr;69(4):367-78. doi: 10.1111/j.1365-2125.2009.03610.x.
5
Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic.聚（ADP - 核糖）聚合酶 -1（PARP - 1）抑制剂的演变。从概念到临床应用。
J Med Chem. 2010 Jun 24;53(12):4561-84. doi: 10.1021/jm100012m.
6
Cancer research. Melanoma drug vindicates targeted approach.癌症研究。黑色素瘤药物证明了靶向治疗方法的有效性。
Science. 2009 Dec 18;326(5960):1619. doi: 10.1126/science.326.5960.1619.
7
Iterative in situ click chemistry creates antibody-like protein-capture agents.迭代原位点击化学法制备抗体样蛋白质捕获剂。
Angew Chem Int Ed Engl. 2009;48(27):4944-8. doi: 10.1002/anie.200900488.
8
Screening and prostate-cancer mortality in a randomized European study.一项欧洲随机研究中的筛查与前列腺癌死亡率
N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.
9
Imaging in the era of molecular oncology.分子肿瘤学时代的影像学
Nature. 2008 Apr 3;452(7187):580-9. doi: 10.1038/nature06917.
10
The cancer biomarker problem.癌症生物标志物问题。
Nature. 2008 Apr 3;452(7187):548-52. doi: 10.1038/nature06913.
Zotero 插件